Pilot Study to Assess the Efficacy of and Tolerance to a QUadruple Therapy to Treat HIV-HCV Coinfected Patients Previously Null Responders

NCT01725542 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

OTHER_GOV

Sponsor class

Conditions

HCV-HIV Co-Infection

Interventions

DRUG: Asunaprevir, Daclatasvir, Ribavirin and Peginterferon alfa-2a

Sponsor

ANRS, Emerging Infectious Diseases

Collaborators

[object Object]